Pyxis Oncology Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$3.01

+0.15 (+5.24%)

As of Jun 30, 10:35 PM ET ·

Analyst Consensus

Strong Buy

Analysts

High

Coverage

Buy 13 87%

Hold 2 13%

Sell 0 0%

Price Target

Analyst Price Target +1,404.7% upside

Low Target $33.37

Average Target $45.29

High Target $67.77

Current Price $3.01

Current
$3.01

Target
$45.29

$33.37 $45.29 avg $67.77

Scenario Analysis

Bear Case

$33.37

1,008.6%

Low target

Base Case

$45.29

+1,404.7%

Avg target

Bull Case

$67.77

+2,151.5%

High target

Risk/Reward

2.1x

Favorable

Price in Context

52-Week High

$5.55

-45.8% from high

52-Week Low

$0.97

+210.3% from low

Target vs 52W High

$45.29

+716.0% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	40	78%	$257.58	+2.4%
AMGN Amgen Inc	Hold	44	50%	$190.87	-47.3%
GILD Gilead Sciences Inc	Strong Buy	39	82%	$362.68	+187.1%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	40	83%	$438.34	-11.8%
REGN Regeneron Pharmaceuticals	Buy	38	71%	$76.80	-87.7%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	37	76%	$102.31	-66.0%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-39.1%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-47.4%